Cargando…
Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here, we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathog...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385207/ https://www.ncbi.nlm.nih.gov/pubmed/35920621 http://dx.doi.org/10.7554/eLife.76223 |
_version_ | 1784769543166492672 |
---|---|
author | Bi, Yanxia Su, Jian Zhou, Shengru Zhao, Yingjie Zhang, Yan Zhang, Huihui Liu, Mingdong Zhou, Aiwu Xu, Jianrong Pan, Meng Zhao, Yiming Li, Fubin |
author_facet | Bi, Yanxia Su, Jian Zhou, Shengru Zhao, Yingjie Zhang, Yan Zhang, Huihui Liu, Mingdong Zhou, Aiwu Xu, Jianrong Pan, Meng Zhao, Yiming Li, Fubin |
author_sort | Bi, Yanxia |
collection | PubMed |
description | IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here, we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathogenic function of autoantibodies in different IgG4-mediated diseases in mouse models. While IgG4 and its weak Fc-FcγR interaction have an ameliorative role in the pathogenicity of anti-ADAMTS13 autoantibodies isolated from thrombotic thrombocytopenic purpura (TTP) patients, they have an unexpected exacerbating effect on anti-Dsg1 autoantibody pathogenicity in pemphigus foliaceus (PF) models. Strikingly, a non-pathogenic anti-Dsg1 antibody variant optimized for FcγR-mediated effector function can attenuate the skin lesions induced by pathogenic anti-Dsg1 antibodies by promoting the clearance of dead keratinocytes. These studies suggest that IgG effector function contributes to the clearance of autoantibody-Ag complexes, which is harmful in TTP, but beneficial in PF and may provide new therapeutic opportunity. |
format | Online Article Text |
id | pubmed-9385207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-93852072022-08-18 Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases Bi, Yanxia Su, Jian Zhou, Shengru Zhao, Yingjie Zhang, Yan Zhang, Huihui Liu, Mingdong Zhou, Aiwu Xu, Jianrong Pan, Meng Zhao, Yiming Li, Fubin eLife Immunology and Inflammation IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here, we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathogenic function of autoantibodies in different IgG4-mediated diseases in mouse models. While IgG4 and its weak Fc-FcγR interaction have an ameliorative role in the pathogenicity of anti-ADAMTS13 autoantibodies isolated from thrombotic thrombocytopenic purpura (TTP) patients, they have an unexpected exacerbating effect on anti-Dsg1 autoantibody pathogenicity in pemphigus foliaceus (PF) models. Strikingly, a non-pathogenic anti-Dsg1 antibody variant optimized for FcγR-mediated effector function can attenuate the skin lesions induced by pathogenic anti-Dsg1 antibodies by promoting the clearance of dead keratinocytes. These studies suggest that IgG effector function contributes to the clearance of autoantibody-Ag complexes, which is harmful in TTP, but beneficial in PF and may provide new therapeutic opportunity. eLife Sciences Publications, Ltd 2022-08-03 /pmc/articles/PMC9385207/ /pubmed/35920621 http://dx.doi.org/10.7554/eLife.76223 Text en © 2022, Bi et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Immunology and Inflammation Bi, Yanxia Su, Jian Zhou, Shengru Zhao, Yingjie Zhang, Yan Zhang, Huihui Liu, Mingdong Zhou, Aiwu Xu, Jianrong Pan, Meng Zhao, Yiming Li, Fubin Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases |
title | Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases |
title_full | Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases |
title_fullStr | Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases |
title_full_unstemmed | Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases |
title_short | Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases |
title_sort | distinct impact of igg subclass on autoantibody pathogenicity in different igg4-mediated diseases |
topic | Immunology and Inflammation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385207/ https://www.ncbi.nlm.nih.gov/pubmed/35920621 http://dx.doi.org/10.7554/eLife.76223 |
work_keys_str_mv | AT biyanxia distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases AT sujian distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases AT zhoushengru distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases AT zhaoyingjie distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases AT zhangyan distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases AT zhanghuihui distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases AT liumingdong distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases AT zhouaiwu distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases AT xujianrong distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases AT panmeng distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases AT zhaoyiming distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases AT lifubin distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases |